Related Experiment Video
Updated: Aug 4, 2025

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
Recurrent wheezing phenotypes after severe bronchiolitis and progression to asthma
Jonathan M Mansbach1, Qi Shelly Ying2, Janice A Espinola2
1Department of Pediatrics, Boston Children's Hospital, Boston.
Insights
Severe wheezing phenotypes in infants hospitalized for bronchiolitis are linked to childhood asthma. Depending on the specific wheezing phenotype, 33% to 54% of children may develop asthma by age 6.
Area of Science:
- Pediatric Respiratory Medicine
- Asthma Research
- Clinical Cohort Studies
Background:
- Recurrent wheezing is a common diagnosis following severe bronchiolitis in infants.
- The relationship between different recurrent wheezing phenotypes and the development of childhood asthma remains unclear.
Purpose of the Study:
- To investigate the association between three recurrent wheezing phenotypes defined in 2020 and the subsequent development of asthma by age 6.
- To compare these phenotypes with the 2007 National Heart, Lung, and Blood Institute (NHLBI) recurrent wheezing definition.
Main Methods:
- A 17-center cohort study involving infants hospitalized with bronchiolitis.
- Phenotyping of recurrent wheezing (NHLBI 2020, multitrigger, severe) by age 4 and assessment for asthma by age 6.
- Multivariable logistic regression analysis to identify characteristics of high-risk phenotypes.
Main Results:
- By age 4, a majority of infants met criteria for NHLBI 2020 recurrent wheezing (69%), multitrigger wheezing (80%), or severe wheezing (18%).
- By age 6, 28% of children developed asthma.
- The proportion of children who developed asthma varied by phenotype: 33% for NHLBI 2020 and multitrigger wheezing, and 54% for the severe phenotype.
Conclusions:
- Infants with severe bronchiolitis frequently develop recurrent wheezing phenotypes by age 4.
- A significant proportion of children, ranging from 33% to 54%, may progress to asthma by age 6, with the severe phenotype posing the highest risk.
- Further research is needed to explore early interventions for high-risk wheezing phenotypes to potentially prevent childhood asthma.
Background:
Recurrent wheezing, a common diagnosis after severe bronchiolitis, has multiple phenotypes of uncertain relation to childhood asthma.
Objective:
Among infants hospitalized for bronchiolitis, we investigated the relation of three 2020 recurrent wheezing phenotypes by age 4 years to asthma by age 6 years.
Methods:
In a 17-center cohort study of infants hospitalized with bronchiolitis, we investigated the National Heart, Lung, and Blood Institute (NHLBI) 2020-defined recurrent wheezing phenotype and 2 additional phenotypes based on this definition: multitrigger and severe. As a sensitivity analysis, we examined the NHLBI 2007 recurrent wheezing phenotype. We calculated the proportion of study subjects who developed asthma by age 6 years and used multivariable logistic regression to examine characteristics associated with the highest-risk 2020 phenotype.
Results:
Of 921 infants, 632 (69%) developed NHLBI 2020 recurrent wheezing, 734 (80%) developed multitrigger wheezing, and 165 (18%) developed severe wheezing by age 4 years; in addition, 296 (32%) developed NHLBI 2007-defined recurrent wheezing by age 3 years. Of 862 children with sufficient data (94%), 239 (28%) developed asthma by age 6 years. The proportions of children who progressed to asthma were as follows: 33% of those with NHLBI 2020-defined wheezing, 33% of those with multitrigger wheezing, 54% of those with severe wheezing, and 52% of those with NHLBI 2007-defined recurrent wheezing. The children with the severe phenotype who developed asthma had the associated characteristics preterm birth, child eczema, maternal asthma, and non-respiratory syncytial virus infection.
Conclusion:
Most infants with severe bronchiolitis developed the NHLBI 2020-defined recurrent wheezing phenotype by age 4 years. Depending on the phenotype, 33% to 54% will develop asthma by age 6 years. Future research will examine whether earlier treatment of high-risk phenotypes will improve wheezing symptoms and potentially prevent childhood asthma. (J Allergy Clin Immunol Global 2023;2:84-7.).
Related Concept Videos
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pulmonary Cycle: Exhalation

